Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Testing effectiveness (Phase 2)Looking for participantsNCT02734537What this trial is testingRadiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone SurgeryWho this might be right forHead and Neck Squamous Cell CarcinomaHypopharyngeal Squamous Cell CarcinomaLaryngeal Squamous Cell Carcinoma+13 more ECOG-ACRIN Cancer Research Group 189
Not applicableStudy completedNCT01504932What this trial is testingFreeze-Dried Black Raspberries in Preventing Oral Cancer Recurrence in High At-Risk Appalachian Patients Oral Cancer SurvivorsWho this might be right forStage I Squamous Cell Carcinoma of the Lip and Oral CavityStage I Squamous Cell Carcinoma of the OropharynxStage I Verrucous Carcinoma of the Oral Cavity+16 more Ohio State University Comprehensive Cancer Center 42
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT01334177What this trial is testingTLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and NeckWho this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+38 more University of Washington 13
Testing effectiveness (Phase 2)Study completedNCT00095628What this trial is testingSB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck CancerWho this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+19 more National Cancer Institute (NCI) 21
Early research (Phase 1)Study completedNCT00031681What this trial is testing7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)Who this might be right forAdvanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more National Cancer Institute (NCI) 41
Not applicableLooking for participantsNCT01473784What this trial is testingTransoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and NeckWho this might be right forRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Mucoepidermoid Carcinoma of the Oral CavityRecurrent Squamous Cell Carcinoma of the Hypopharynx+48 more Ohio State University Comprehensive Cancer Center 600
Testing effectiveness (Phase 2)Study completedNCT00939627What this trial is testingPhase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent CetuximabWho this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+34 more National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)Study completedNCT00513435What this trial is testingSaracatinib in Treating Patients With Recurrent or Metastatic Head and Neck CancerWho this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Squamous Cell Carcinoma of the Hypopharynx+36 more National Cancer Institute (NCI) 9
Early research (Phase 1)Study completedNCT01254617What this trial is testingLenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck CancerWho this might be right forRecurrent Colon CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+39 more National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Ended earlyNCT02196168What this trial is testingCisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck CancerWho this might be right forRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous Carcinoma+26 more National Cancer Institute (NCI) 6
Early research (Phase 1)Study completedNCT00030498What this trial is testingErlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more National Cancer Institute (NCI) 75
Testing effectiveness (Phase 2)Study completedNCT02123511What this trial is testingAcetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation TherapyWho this might be right forMucositisOral ComplicationsRecurrent Adenoid Cystic Carcinoma of the Oral Cavity+80 more Mayo Clinic 34
Early research (Phase 1)WithdrawnNCT01728480What this trial is testingEntolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation TherapyWho this might be right forMucositisRecurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the Larynx+35 more Roswell Park Cancer Institute
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT00049283What this trial is testingErlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck CancerWho this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaStage III Squamous Cell Carcinoma of the HypopharynxStage III Squamous Cell Carcinoma of the Larynx+24 more National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT00114283What this trial is testingLapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck CancerWho this might be right forRecurrent Salivary Gland CancerRecurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the Larynx+31 more National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT01637194What this trial is testingCetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck CancerWho this might be right forRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the LipRecurrent Colon Cancer+46 more Fox Chase Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT01469429What this trial is testingPhase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.Who this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaSalivary Gland Squamous Cell CarcinomaStage 0 Hypopharyngeal Cancer+55 more Ohio State University Comprehensive Cancer Center 70